Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human
G M Leinninger1, J W Russell, C M van Golen
1Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Neuroblastoma, a pediatric peripheral nervous system tumor, frequently contains alterations in apoptotic pathways, producing chemoresistant disease. Insulin-like growth factor (IGF) system components are highly expressed in neuroblastoma, further protecting these cells from apoptosis. This study investigates IGF-I regulation of apoptosis at the mitochondrial level. Elevated extracellular glucose causes rapid mitochondrial enlargement coupled with an increase in the mitochondrial membrane potential (Delta Psi(M)) followed by mitochondrial membrane depolarization (MMD), uncoupling protein 3 (UCP3) downregulation, caspase-3 activation and decreased Bcl-2. MMD inhibition by Bongkrekic acid prevents high-glucose-induced loss of UCP3 and apoptosis. Glucose exposure induces caspase-9 cleavage within 30 min, and caspase-9 inhibition prevents glucose-mediated apoptosis. IGF-I prevents caspase activation and mitochondrial events leading to apoptosis. These results suggest that elevated glucose produces early initiator caspase activation, followed by Delta Psi(M) changes, in neuroblastoma cells; in turn, IGF-I prevents apoptosis by preventing downstream caspase activation, maintaining Delta Psi(M) and regulating Bcl proteins.
Insights
High glucose levels trigger apoptosis in neuroblastoma cells by affecting mitochondria and caspases. Insulin-like growth factor I (IGF-I) protects these cells from this programmed cell death.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Neuroblastoma, a pediatric nervous system tumor, exhibits chemoresistance due to altered apoptotic pathways.
- Insulin-like growth factor (IGF) system components are highly expressed in neuroblastoma, promoting cell survival by inhibiting apoptosis.
Purpose of the Study:
- To investigate the role of IGF-I in regulating apoptosis at the mitochondrial level in neuroblastoma cells.
- To elucidate the mechanisms by which elevated glucose affects apoptosis in neuroblastoma.
Main Methods:
- Mitochondrial membrane potential (Delta Psi(M)) and mitochondrial membrane depolarization (MMD) were measured.
- Caspase activation (caspase-3 and caspase-9), uncoupling protein 3 (UCP3) expression, and Bcl-2 levels were assessed.
- The effects of Bongkrekic acid and caspase-9 inhibition on glucose-induced apoptosis were evaluated.
Main Results:
- Elevated extracellular glucose induced rapid mitochondrial enlargement, increased Delta Psi(M), followed by MMD, UCP3 downregulation, caspase-3 activation, and decreased Bcl-2.
- MMD inhibition prevented high-glucose-induced UCP3 loss and apoptosis.
- Glucose exposure triggered caspase-9 cleavage within 30 minutes, and caspase-9 inhibition blocked glucose-mediated apoptosis.
- IGF-I effectively prevented caspase activation and the mitochondrial events leading to apoptosis.
Conclusions:
- Elevated glucose initiates apoptosis in neuroblastoma cells via early caspase activation and subsequent mitochondrial changes.
- IGF-I confers protection by inhibiting downstream caspase activation, preserving mitochondrial membrane potential, and regulating Bcl proteins, thereby preventing apoptosis.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway


